BACKGROUND: Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high ...

Hello and welcome to this week's edition of Circulation on the Run. My name is Dr. Pishoy Gouda from the University of Alberta, and I'm joined today with Dr. Alexander Fanaroff from the University of ...

Abstract We investigated the effects of angiotensin II (Ang II) type 1 receptor blockade with losartan on the renin-angiotensin-aldosterone system in hypertensive patients (supine diastolic blood ...

In this issue of Stroke, Butcher et al 7 present the results of the DATAS II (Dabigatran Treatment of Non-Acute Cardioembolic Ischemic Stroke Trial), a phase II prospective, randomized, open label, ...

Nursing is an essential part of our health care system workforce. Cardiovascular and stroke nursing represents one of the largest specialty areas requiring expert knowledge and clinical proficiency to ...

Request permissions for this article.

The prevalence and impact of right ventricular dysfunction (RVD) in degenerative mitral regurgitation (DMR) is unknown. We aimed to determine whether RVD assessed by echocardiography in routine ...

View all available purchase options and get full access to this article.

Valvular heart disease poses an escalating global health challenge with an increasing impact on mortality and disability. This study aims to comprehensively analyze the global burden of valvular heart ...

Mitochondrial dysfunction is a key factor in the development of atherogenesis. METTL4 (methyltransferase-like protein 4) mediates N6- methyldeoxyadenosine (6mA) of mammalian mitochondrial DNA (mtDNA).